BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27923569)

  • 1. Gender differences of B cell signature related to estrogen-induced IFI44L/BAFF in systemic lupus erythematosus.
    Fan H; Zhao G; Ren D; Liu F; Dong G; Hou Y
    Immunol Lett; 2017 Jan; 181():71-78. PubMed ID: 27923569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
    Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
    J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.
    Jacob N; Guo S; Mathian A; Koss MN; Gindea S; Putterman C; Jacob CO; Stohl W
    J Immunol; 2011 Apr; 186(8):4984-93. PubMed ID: 21383240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
    Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
    Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus.
    Dong G; Yang Y; Li X; Yao X; Zhu Y; Zhang H; Wang H; Ma Q; Zhang J; Shi H; Ning Z; Yan F; Zhai W; Dai J; Li Z; Li C; Ming J; Xue Q; Meng X; Si C; Xiong H
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165554. PubMed ID: 31513833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
    Saidoune F; Even G; Lamri Y; Chezel J; Gaston AT; Escoubet B; Papo T; Charles N; Nicoletti A; Sacre K
    Arthritis Rheumatol; 2021 Feb; 73(2):255-264. PubMed ID: 32783382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus.
    Vincent FB; Morand EF; Mackay F
    Immunol Cell Biol; 2012 Mar; 90(3):293-303. PubMed ID: 22231653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.
    Nzeusseu Toukap A; Galant C; Theate I; Maudoux AL; Lories RJ; Houssiau FA; Lauwerys BR
    Arthritis Rheum; 2007 May; 56(5):1579-88. PubMed ID: 17469140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of BAFF and BR3 in patients with systemic lupus erythematosus.
    Duan JH; Jiang Y; Mu H; Tang ZQ
    Braz J Med Biol Res; 2016 Mar; 49(3):. PubMed ID: 26840704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of CD19 autoimmunity marker on B cells of paediatric SLE patients through repressing PU.1/TNF-α/BAFF axis pathway by miR-155.
    Aboelenein HR; Hamza MT; Marzouk H; Youness RA; Rahmoon M; Salah S; Abdelaziz AI
    Growth Factors; 2017 Jun; 35(2-3):49-60. PubMed ID: 28683581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.
    Zhao M; Zhou Y; Zhu B; Wan M; Jiang T; Tan Q; Liu Y; Jiang J; Luo S; Tan Y; Wu H; Renauer P; Del Mar Ayala Gutiérrez M; Castillo Palma MJ; Ortega Castro R; Fernández-Roldán C; Raya E; Faria R; Carvalho C; Alarcón-Riquelme ME; Xiang Z; Chen J; Li F; Ling G; Zhao H; Liao X; Lin Y; Sawalha AH; Lu Q
    Ann Rheum Dis; 2016 Nov; 75(11):1998-2006. PubMed ID: 26787370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen.
    Fan H; Dong G; Zhao G; Liu F; Yao G; Zhu Y; Hou Y
    J Immunol Res; 2014; 2014():814598. PubMed ID: 24741625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    Rodríguez-Carrio J; López P; Alperi-López M; Caminal-Montero L; Ballina-García FJ; Suárez A
    Front Immunol; 2018; 9():3085. PubMed ID: 30666255
    [No Abstract]   [Full Text] [Related]  

  • 15. B-cell activating factor and related genetic variants in lupus related atherosclerosis.
    Theodorou E; Nezos A; Antypa E; Ioakeimidis D; Koutsilieris M; Tektonidou M; Moutsopoulos HM; Mavragani CP
    J Autoimmun; 2018 Aug; 92():87-92. PubMed ID: 29859654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of mRNA, microRNA and protein in systemic lupus erythematosus-specific induced pluripotent stem cells from urine.
    Tang D; Chen Y; He H; Huang J; Chen W; Peng W; Lu Q; Dai Y
    BMC Genomics; 2016 Jul; 17():488. PubMed ID: 27402083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?
    Binard A; Le Pottier L; Saraux A; Devauchelle-Pensec V; Pers JO; Youinou P
    J Autoimmun; 2008; 30(1-2):63-7. PubMed ID: 18155417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF/BAFF-R signal pathway.
    Wu DH; Xu L; Wen CP; Xie GQ; Ji JJ; Pan JL; Jiao YF; Fan YS
    PLoS One; 2015; 10(2):e0118462. PubMed ID: 25689512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon
    Akita K; Yasaka K; Shirai T; Ishii T; Harigae H; Fujii H
    Front Immunol; 2020; 11():498703. PubMed ID: 33633721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of IFI44L as a new candidate molecular marker for systemic lupus erythematosus.
    Wang Y; Jia W; Ma Q; Li F; Ma Z; Yang M; Pu J; Huo Z; Dang J
    Clin Exp Rheumatol; 2023 Jan; 41(1):48-59. PubMed ID: 35349411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.